Promeditec and ANSYS [Case Study]
Luca Emili, CEO of In Silico Trials, discusses the importance of using modern technologies like simulation to accelerate the FDA medical device and pharmaceutical approval process.
Luca Emili, CEO of In Silico Trials, discusses the importance of using modern technologies like simulation to accelerate the FDA medical device and pharmaceutical approval process.